Hodgkin's lymphoma staging: Difference between revisions
No edit summary |
No edit summary |
||
Line 20: | Line 20: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | I | | style="padding: 5px 5px; background: #F5F5F5;" | I | ||
| style="padding: 5px 5px; background: #F5F5F5;" | One node or a group of adjacent nodes | | style="padding: 5px 5px; background: #F5F5F5;" | One node or a group of adjacent nodes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Single | | style="padding: 5px 5px; background: #F5F5F5;" | Single extra nodal lesions without nodal involvement | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | II | | style="padding: 5px 5px; background: #F5F5F5;" | II | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Two or more nodal groups on the same side of the diaphragm | | style="padding: 5px 5px; background: #F5F5F5;" | Two or more nodal groups on the same side of the diaphragm | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage I or II by nodal extent with limited contiguous | | style="padding: 5px 5px; background: #F5F5F5;" | Stage I or II by nodal extent with limited contiguous extra nodal involvement | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | II bulky* | | style="padding: 5px 5px; background: #F5F5F5;" | II bulky* | ||
Line 37: | Line 37: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | IV | | style="padding: 5px 5px; background: #F5F5F5;" | IV | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Additional noncontiguous | | style="padding: 5px 5px; background: #F5F5F5;" | Additional noncontiguous extra lymphatic involvement | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Not applicable | | style="padding: 5px 5px; background: #F5F5F5;" | Not applicable | ||
|} | |} | ||
Line 52: | Line 52: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | IE | | style="padding: 5px 5px; background: #F5F5F5;" | IE | ||
| style="padding: 5px 5px; background: #F5F5F5;" | One | | style="padding: 5px 5px; background: #F5F5F5;" | One extra nodal site | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''stage II''' | | style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''stage II''' | ||
Line 60: | Line 60: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | II E | | style="padding: 5px 5px; background: #F5F5F5;" | II E | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Localised | | style="padding: 5px 5px; background: #F5F5F5;" | Localised extra nodal site with stage II criteria, both on the same side of the diaphragm | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''stage III''' | | style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''stage III''' | ||
Line 116: | Line 116: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | D | | style="padding: 5px 5px; background: #F5F5F5;" | D | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Skin | | style="padding: 5px 5px; background: #F5F5F5;" | Skin | ||
|} | |} | ||
Revision as of 16:01, 18 September 2015
Hodgkin's lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hodgkin's lymphoma staging On the Web |
American Roentgen Ray Society Images of Hodgkin's lymphoma staging |
Risk calculators and risk factors for Hodgkin's lymphoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
According to the Lugano classification and Cotswold's modification of the original Ann arbor staging system, there are four stages of Hodgkin's lymphoma based on the number of nodes and extranodal involvement.
Staging
According to the Lugano classification[1]and Cotswold's modification of the original Ann arbor staging system,[2][3] there are four stages of Hodgkin's lymphoma based on the number of nodes and extranodal involvement.
Staging for Hodgkin's lymphoma is provided in the following tables:
Stage | Involvement | Extranodal (E) status |
---|---|---|
Limited | ||
I | One node or a group of adjacent nodes | Single extra nodal lesions without nodal involvement |
II | Two or more nodal groups on the same side of the diaphragm | Stage I or II by nodal extent with limited contiguous extra nodal involvement |
II bulky* | II as above with "bulky" disease | Not applicable |
Advanced | ||
III | Nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement | Not applicable |
IV | Additional noncontiguous extra lymphatic involvement | Not applicable |
Stage | Involvement | |
---|---|---|
stage I | ||
I | One nodal group or lymphoid organ (e.g. spleen or thymus) | |
IE | One extra nodal site | |
stage II | ||
II | Two or more nodal groups, same side of diaphragm | |
II E | Localised extra nodal site with stage II criteria, both on the same side of the diaphragm | |
stage III | ||
III | Nodal groups on both sides of the diaphragm | |
III S (1) | With splenic involvement | |
III E (2) | With localised extranodal site | |
III SE | Both | |
stage IV | ||
IV | Disseminated involvement of one or more extralymphatic organ (e.g. lung, bone) +/- any nodal involvement | |
Additional staging variables | ||
X | Bulky nodal disease: nodal mass >1/3 of intra thoracic diameter or 10 cm in dimension | |
A | Asymptomatic | |
B | Presence of B symptoms (fever, night sweats and weight loss) | |
E | Extranodal: other than the lymph nodes or spread to tissues beyond, but nearby, the lymphatic tissues | |
S | Spleen | |
N | Lymph nodes | |
H | Liver | |
L | Lung | |
M | Bone marrow | |
O | Bone | |
D | Skin |
-
Stage 1 Hodgkin's lymphoma
-
Stage 2 Hodgkin's lymphoma
-
Stage 3 Hodgkin's lymphoma
-
Stage 4 Hodgkin's lymphoma
References
- ↑ Cheson, Bruce D.; Fisher, Richard I.; Barrington, Sally F.; Cavalli, Franco; Schwartz, Lawrence H.; Zucca, Emanuele; Lister, T. Andrew; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute (2014-09-20). "Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification". Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 32 (27): 3059–3068. doi:10.1200/JCO.2013.54.8800. ISSN 1527-7755. PMID 25113753.
- ↑ "Radiopaedia Lymphoma staging".
- ↑ "Canadian Cancer Society Stages of Hodgkin lymphoma".